Science, Computers & Technology Civil Procedure Government Contracting

False Claims Act (FCA) Pharmaceutical Industry Qui Tam Medical Devices Off-Label Promotion Prescription Drugs FDA Federal Contractors Relators Whistleblowers Dismissals Medicaid Health Care Providers Anti-Kickback Statute DOJ Pleading Standards Fraud Off-Label Use Popular CMS Corporate Counsel HITECH Pharmacies SCOTUS Appeals Cybersecurity Data Breach Healthcare Kickbacks Manufacturers Medicare Medicare Part D Public Disclosure Skilled Nursing Facility Universal Health Services Inc v United States ex rel Escobar Affordable Care Act Class Action Compliance False Implied Certification Theory False Statements First Amendment First-to-File General Services Administration (GSA) Healthcare Fraud HHS HIPAA Hospitals Long Term Care Facilities Materiality Motion to Amend Motion to Dismiss NIH Novartis Omnicare Patents Pfizer PHI Rule 9(b) Summary Judgment Abbott Laboratories Attorney-Client Privilege Construction Industry Damages Data Protection DFARS Direct Infringement FDA Approval Federal Acquisition Regulations (FAR) Federal Rules of Civil Procedure HELP Hospice Legislative Agendas Litigation Strategies Marketing OIG Patent Infringement Patent Litigation Preliminary Injunctions Retaliation Scienter Subpoenas Trade Agreements Act TSA 60-Day Rule Acquisitions Administrative Procedure Act Admissible Evidence Affirmative Defenses Amarin Amended Complaints American Bar Association (ABA) Anti-Retaliation Provisions Anti-Steering Rules Auction Audits Aviation Industry Bailments Bayer Bayh-Dole Act Bid Protests Biosimilars Blacklist Board of Directors Bribery Bristol-Myers Squibb Burden of Proof Certifications Chief Compliance Officers CHIP Civil Monetary Penalty Confidential Information Consolidated Appropriations Act Coupons Criminal Prosecution Cyber Attacks Cyber Crimes Data Breach Plans Data Privacy Data Security Davis-Bacon Act Declaratory Relief Department of Defense (DOD) Department of Health and Human Services Department of Insurance Discovery Distributors Drug Pricing Due Process Dukes v Wal-Mart EHR Eli Lilly EMTs Enforcement Actions Evidence Exclusive Remedy Executive Orders Expert Testimony Failure To State A Claim Fair Pay and Safe Workplaces False Advertising False Billing FCPA Federal Health Care Programs (FHCP) First-Filed Action Rule FISMA Form 10-K Former Employee Fraud and Abuse FRCP 9(b) Free Speech Frivolous Lawsuits FTC GAO Genentech Generic Drugs Genuine Issue of Material Fact Gilead Sciences Government Investigations Hackers Health Insurance Healthcare Costs Hearsay Hip Replacement Hoffman LaRoche Home Health Care Hospital Mergers ICD-10 Implied Certification Indirect Infringement Individual Accountability Induced Infringement Interlocutory Appeals Internet Auctions Interstate Commerce Investigations Jury Verdicts KBR (formerly Kellogg Brown & Root) Legal Ethics License Agreements Licenses Long-Term Care Managed Care Contracts Medicaid Reimbursements Medical Supplies Medicare Access and CHIP Reauthorization (MACRA) Medicare Part B MedPAC Medtronic Misappropriation Misbranding Misleading Statements Misrepresentation Narcotics NDAA NLRA OCR OMB Online Reviews Open Enrollment OPM Overpayment Overpayment Recovery Time Limits Passports Patient Safety Pay Transparency Pay-For-Delay Peer Review Pending Legislation Personally Identifiable Information Petition for Writ of Certiorari Physician Medicare Reimbursements Physicians Planned Parenthood Pleadings Prescription Drug Coverage Privacy Policy Privilege Waivers Product Defects Professional Liability Prompt Payment Purchase Price Qualified Health Plans Regulatory Standards Reimbursements Reporting Requirements Res Judicata Reversal Reverse False Claims Risk Management Rule Rule 26 SAMHSA Sealed Records Security Breach Self-Authentication Senate Finance Committee Service Contract Act Settlement Settlement Agreements Social Security Administration (SSA) Software Stark Law Statistical Sampling Stem cells Supplemental Information Suppliers Supply Chain Takeda Pharmaceuticals Takedown Notices Third-Party Third-Party Beneficiaries Threshold Requirements Trade Secrets Unjust Enrichment US Department of State Whistleblower Protection Policies Witness Preparation Wyeth Yates Memorandum Zika